Patents Represented by Law Firm Cooley Godward Castro Huddleson & Tatum
  • Process for reducing the discoloration of wood
    Patent number: 5077098
    Abstract: A process for protecting wood by applying to the wood an aqueous solution of a composition comprising sodium borate and sodium carbonate. Adverse effects on the color of the wood are reduced by including in the composition a component selected from a weakly acidic compound able to form a complex with cellulose; the weakly acidic compound and titanium dioxide; an alkyl ammonium chloride; the weakly acidic compound and an alkyl ammonium chloride; and an alkaline earth metal hydroxide.
    Type: Grant
    Filed: January 31, 1990
    Date of Patent: December 31, 1991
    Assignee: Canadian Forest Products Ltd.
    Inventor: Suezone Chow
  • Multisource device for photometric analysis and associated chromogens
    Patent number: 5073029
    Abstract: An optoelectronic device is provided which permits rapid sequential measurement of the optical density of multiple samples. The device employs a plurality of light-emitting diodes (LEDs) as light sources and a plurality of photodiodes as light detectors. In a preferred embodiment, arrays of LEDs paired with photodiodes are adapted to measure the optical density of samples contained in multiwell plastic plates (microplates) conventionally used for immunoassays.
    Type: Grant
    Filed: February 16, 1990
    Date of Patent: December 17, 1991
    Assignee: EQM Research, Inc.
    Inventors: James P. Eberly, Ralph A. Magnotti, Jr.
  • Pharmaceutical combination for treatment of bone-wasting diseases
    Patent number: 5071655
    Abstract: A pharmaceutical composition for increasing bone mass and preventing loss of bone mass is provided, comprising a fluoride source and a mitogenic hydantoin in combination with a pharmaceutically acceptable carrier, in which the fluoride source provides a molar ratio of fluoride ion to hydantoin in the composition of from about 0.1:1 to about 100:1. The combination is administered to a vertebrate, typically in the form of an orally administratable tablet or capsule.
    Type: Grant
    Filed: January 12, 1990
    Date of Patent: December 10, 1991
    Inventor: David J. Baylink
  • In vitro human monoclonal IgG rheumatoid factor autoantibody
    Patent number: 5034316
    Abstract: Human monoclonal IgG RF is provided in stable supply from immortalized cells. The IgG RF can be used for diagnosis and study of rheumatoid arthritis. In addition, anti-idiotype antibodies can be provided for use in diagnosis and therapy.The cell line hRF-1 was deposited at the A.T.C.C. on January 16, 1991 and given accession No. ATCC 10645.
    Type: Grant
    Filed: March 30, 1987
    Date of Patent: July 23, 1991
    Assignee: The Regents of the University of California
    Inventors: Richard H. Weisbart, Romaine E. Saxton